MX2013014428A - Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche. - Google Patents
Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche.Info
- Publication number
- MX2013014428A MX2013014428A MX2013014428A MX2013014428A MX2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A
- Authority
- MX
- Mexico
- Prior art keywords
- nutritional compositions
- milk fat
- fat globule
- membrane components
- globule membrane
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1516—Enrichment or recombination of milk (excepted whey) with milk fat, cream of butter without using isolated or concentrated milk proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
Abstract
Se proporcionan composiciones nutricionales que incluyen componentes de la membrana del glóbulo de grasa de la leche ("MFGM", por sus siglas en inglés) y al menos un nutriente. Los lípidos activos derivados de la leche, ayudan a modular las condiciones que por lo general se encuentran en los ancianos que incluyen, por ejemplo, inflamación de bajo grado, pérdida de la masa corporal magra, inestabilidad de la membrana celular del músculo esquelético, e inflamación articular. Los nutrientes pueden incluir, pero no se limitan a, micelas de proteína de suero de leche, citrulina, ácidos grasos de cadena ramificada, y ácido a-hidroxicaproico ("a-HICA"). También se proporcionan métodos para tratar a un individuo que tiene, o en riesgo de tener, una afección médica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/039612 WO2012170021A1 (en) | 2011-06-08 | 2011-06-08 | Nutritional compositions having exogenous milk fat globule membrane components |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013014428A true MX2013014428A (es) | 2014-03-31 |
Family
ID=44627130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013014428A MX2013014428A (es) | 2011-06-08 | 2011-06-08 | Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20140105875A1 (es) |
EP (1) | EP2717705A1 (es) |
JP (1) | JP2014516565A (es) |
CN (1) | CN103596440A (es) |
AU (1) | AU2011370626A1 (es) |
BR (1) | BR112013031086A2 (es) |
CA (1) | CA2836241A1 (es) |
MX (1) | MX2013014428A (es) |
RU (1) | RU2013158289A (es) |
SG (1) | SG194918A1 (es) |
WO (1) | WO2012170021A1 (es) |
ZA (1) | ZA201400116B (es) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY170185A (en) * | 2011-10-18 | 2019-07-09 | Nestle Sa | Composition for use in brain growth and/or cognitive and/or psychomotor development |
PL2768313T3 (pl) * | 2011-10-18 | 2016-02-29 | Nestec Sa | Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie |
BR112014009097A2 (pt) * | 2011-10-18 | 2017-04-18 | Nestec Sa | composição para uso na promoção de crescimento de osso saudável e/ou na prevenção e/ou tratamento das doenças dos ossos |
ES2550321T3 (es) * | 2011-10-21 | 2015-11-06 | Nestec S.A. | Micelas de proteína de suero para aumentar la masa muscular y el rendimiento |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
JP2014172861A (ja) * | 2013-03-08 | 2014-09-22 | Snow Brand Milk Products Co Ltd | 抗炎症剤 |
WO2014138304A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc., | Rice protein supplements |
JP6158565B2 (ja) * | 2013-04-09 | 2017-07-05 | 花王株式会社 | 筋タンパク質合成シグナル増強剤 |
SE537951C2 (sv) * | 2013-07-01 | 2015-12-01 | Hero Ag | Profylaktisk användning av modersmjölksersättning mot otit |
US9241923B2 (en) * | 2013-07-16 | 2016-01-26 | Mead Johnson Nutrition Company | Methods for promoting neuronal development and/or health |
EP3021942A4 (en) | 2013-07-19 | 2017-04-19 | The Regents of The University of California | Milk fat globule epidermal growth factor 8 regulates fatty acid uptake |
US10709770B2 (en) * | 2013-07-31 | 2020-07-14 | Mead Johnson Nutrition Company | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof |
US11331353B2 (en) | 2014-03-25 | 2022-05-17 | Kabushiki Kaisha Yakult Honsha | Sleep quality improver |
JP6446265B2 (ja) * | 2014-12-26 | 2018-12-26 | 花王株式会社 | 固形状組成物 |
US10525016B2 (en) * | 2015-06-03 | 2020-01-07 | Mead Johnson Nutrition Company | Nutritional compositions containing an elevated level of inositol and uses thereof |
CA3000841A1 (en) * | 2015-10-02 | 2017-04-06 | Glanbia Nutritionals (Ireland) Ltd. | Protein hydrolysate, method for making, and use |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
EP3368498A4 (en) | 2015-10-27 | 2019-06-12 | Cytozyme Animal Nutrition, Inc. | ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS |
WO2017110988A1 (ja) * | 2015-12-25 | 2017-06-29 | 大塚製薬株式会社 | ゲル状食品組成物 |
JP7260951B2 (ja) * | 2016-07-26 | 2023-04-19 | 花王株式会社 | 膝の痛み改善剤 |
JP7260952B2 (ja) * | 2016-07-26 | 2023-04-19 | 花王株式会社 | 肩の痛み改善剤 |
JP7260950B2 (ja) * | 2016-07-26 | 2023-04-19 | 花王株式会社 | 腰痛改善剤 |
JP7397562B2 (ja) * | 2016-07-26 | 2023-12-13 | 花王株式会社 | 腰痛改善剤 |
JP6774675B2 (ja) * | 2016-08-23 | 2020-10-28 | 花王株式会社 | 固形状組成物 |
JP6849390B2 (ja) * | 2016-10-28 | 2021-03-24 | 花王株式会社 | 関節のこわばり改善剤 |
EP3601620A1 (en) | 2017-03-27 | 2020-02-05 | Biogaia Ab | Lactic acid bacteria, methods and uses thereof |
CN107156302A (zh) * | 2017-04-17 | 2017-09-15 | 南昌大学 | 一种含乳脂肪球膜的婴幼儿配方奶粉及制备方法 |
CN110868870A (zh) | 2017-05-12 | 2020-03-06 | 艾斯姆食品公司 | 大米产物及制备它们的系统和方法 |
US11504387B2 (en) * | 2017-11-08 | 2022-11-22 | Societe Des Produits Nestle S.A. | Bioconversion of oleuropein |
BR112020007109A2 (pt) * | 2017-11-08 | 2020-09-24 | Société des Produits Nestlé S.A. | álcool homovanílico (hva), isômero de hva, métodos de fabricação de composições compreendendo tais compostos, e métodos de uso de tais compostos |
JP6987613B2 (ja) * | 2017-11-17 | 2022-01-05 | 花王株式会社 | 固形状組成物 |
CN108558991B (zh) * | 2018-06-29 | 2020-06-09 | 上海铂辉生物科技有限公司 | 一种生物活性多肽giqdpkep及其制备方法和应用 |
WO2020154034A1 (en) * | 2019-01-25 | 2020-07-30 | Children's Medical Center Corporation | Compositions and methods for treating muscular dystrophy and related disorders |
EP3941451A4 (en) * | 2019-03-21 | 2022-12-14 | Fonterra Co-Operative Group Limited | POLAR LIPID COMPOSITIONS TO MAINTAIN OR INCREASE MOBILITY AND VITALITY |
CN114615897A (zh) * | 2019-11-08 | 2022-06-10 | 雅培制药有限公司 | 牛乳分离的粉末状外泌体、营养组合物和方法 |
KR20210069460A (ko) * | 2019-12-03 | 2021-06-11 | 솔루스첨단소재 주식회사 | 유청 유래 극성지질 농축 분획 조성물 및 이의 용도 |
GB2591983A (en) * | 2019-12-04 | 2021-08-18 | Mjn Us Holdings Llc | Compositions and methods for preserving probiotic viability |
CN112042750B (zh) * | 2020-09-09 | 2022-04-05 | 北京三元食品股份有限公司 | 一种富含乳脂肪球膜蛋白、磷脂和低聚糖的婴幼儿配方奶粉及其制备方法 |
DE102020133860A1 (de) * | 2020-12-16 | 2022-06-23 | MNT Systeme GmbH | VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG |
WO2022130317A1 (en) * | 2020-12-17 | 2022-06-23 | Synbalance Srl | Probiotic compositions and their use in the prevention and/or treatment of stress-related conditions |
EP4094591A1 (en) * | 2021-05-28 | 2022-11-30 | Fonterra Co-Operative Group Limited | Food supplement |
CN114128757B (zh) * | 2021-11-30 | 2023-08-04 | 内蒙古伊利实业集团股份有限公司 | 乳脂肪球膜在减少乳制品异味中的应用 |
CN114794491A (zh) * | 2022-05-13 | 2022-07-29 | 北京名投营养科技有限公司 | 一种改善脑功能的组合物及其制备方法 |
WO2024089179A1 (en) * | 2022-10-28 | 2024-05-02 | Frieslandcampina Nederland B.V. | Dairy lipid for lowering the glycoprotein acetyls (glyca) |
CN115997937B (zh) * | 2022-12-13 | 2024-03-12 | 黑龙江飞鹤乳业有限公司 | 含有乳脂肪球膜的营养组合物、用途及食品 |
NL2034054B1 (en) * | 2023-01-30 | 2024-08-16 | Efnatics B V | Composition and method of preparation of bioactive triterpenoid milk fat globule formulations |
CN116904378B (zh) * | 2023-09-14 | 2023-12-29 | 山东中科嘉亿生物工程有限公司 | 促进骨成长的约氏乳杆菌jylo-010及菌剂、应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0322589B1 (fr) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques |
EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
ATE524073T1 (de) * | 2006-03-27 | 2011-09-15 | Nestec Sa | Molkenprotein micellen |
EP1880612A1 (fr) * | 2006-07-17 | 2008-01-23 | Corman S.A. | Ingrédient laitier enrichi en lipides polaires et applications de celui-ci |
FR2908605A1 (fr) * | 2006-11-21 | 2008-05-23 | Groupe Lactalis | Utilisation d'un ingredient contenant un concentre de membranes de globules gras du lait,pour la fabrication d'un aliment,d'une boisson ou d'un supplement alimentaire destine a une indication impliquant la paroi intestinale |
WO2008124648A1 (en) * | 2007-04-05 | 2008-10-16 | Kelly Cox | Butter related food product and method |
CN101589757A (zh) * | 2008-05-28 | 2009-12-02 | 北京健健康康生物技术有限公司 | 一种瓜氨酸冰淇淋及其制备方法 |
MX2012000943A (es) * | 2009-07-20 | 2012-02-28 | Nestec Sa | Metodos para atenuar la perdida de estatus funcional. |
BR112012013766A2 (pt) * | 2009-12-08 | 2015-09-15 | Nestec Sa | "fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite" |
-
2011
- 2011-06-08 CA CA2836241A patent/CA2836241A1/en not_active Abandoned
- 2011-06-08 AU AU2011370626A patent/AU2011370626A1/en not_active Abandoned
- 2011-06-08 SG SG2013083787A patent/SG194918A1/en unknown
- 2011-06-08 BR BR112013031086A patent/BR112013031086A2/pt not_active IP Right Cessation
- 2011-06-08 RU RU2013158289/10A patent/RU2013158289A/ru unknown
- 2011-06-08 WO PCT/US2011/039612 patent/WO2012170021A1/en active Application Filing
- 2011-06-08 US US14/123,700 patent/US20140105875A1/en not_active Abandoned
- 2011-06-08 JP JP2014514440A patent/JP2014516565A/ja not_active Withdrawn
- 2011-06-08 CN CN201180071469.9A patent/CN103596440A/zh active Pending
- 2011-06-08 EP EP11726024.0A patent/EP2717705A1/en not_active Withdrawn
- 2011-06-08 MX MX2013014428A patent/MX2013014428A/es unknown
-
2014
- 2014-01-07 ZA ZA2014/00116A patent/ZA201400116B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2014516565A (ja) | 2014-07-17 |
RU2013158289A (ru) | 2015-07-20 |
BR112013031086A2 (pt) | 2016-11-29 |
CN103596440A (zh) | 2014-02-19 |
SG194918A1 (en) | 2013-12-30 |
EP2717705A1 (en) | 2014-04-16 |
WO2012170021A1 (en) | 2012-12-13 |
CA2836241A1 (en) | 2012-12-13 |
ZA201400116B (en) | 2017-09-27 |
US20140105875A1 (en) | 2014-04-17 |
AU2011370626A1 (en) | 2013-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013014428A (es) | Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche. | |
Summer et al. | Cheese as functional food: The example of Parmigiano Reggiano and Grana Padano | |
EA201071246A1 (ru) | Детское питание на основе жиров молочного происхождения | |
MX2019000228A (es) | Formula nutricional. | |
PH12015501751A1 (en) | Nutritional compositions containing an enriched lipid fraction and uses thereof | |
MY167583A (en) | Infant formula with high sn-2 palmitate and oligofructose | |
PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
WO2008005869A3 (en) | Infant formulas for early brain development | |
MX2013012230A (es) | Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas. | |
SG193246A1 (en) | Nutritional compositions for increasing arginine levels and methods of using same | |
IN2014DN02048A (es) | ||
CN103315299A (zh) | 一种具有增强免疫力和记忆力功能的保健食品 | |
PH12016500894A1 (en) | Pediatric nutritional composition with milk peptides for healthy growth and development | |
RU2013140443A (ru) | Питательные композиции с высоким содержанием белка и способы их приготовления и применения | |
PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
Silva et al. | Sodium reduction and flavor enhancers addition: is there an impact on the availability of minerals from probiotic Prato cheese? | |
AR073234A1 (es) | Precarga de proteina de suero. | |
MY170876A (en) | Dairy product and process | |
MX2022000464A (es) | Metodo de induccion de saciedad. | |
Jakopović et al. | Bioactive components derived from bovine milk | |
JP6093300B2 (ja) | がんに伴う不可逆性の代謝障害の予防及び/又は改善のための組成物 | |
MX370545B (es) | Composiciones y metodos para la administracion de nutrientes. | |
US20130089638A1 (en) | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes | |
Sato et al. | Low contents of polyunsaturated fatty acids in cultured rat cardiomyocytes | |
WO2015095570A3 (en) | Nutritional composition comprising hydrolyzed protein |